Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM:
John S. O'Brien, Director, Legislative Budget Board
IN RE:
HB19 by Leibowitz (Relating to the labeling requirements for drugs dispensed by pharmacists.), As Introduced
No significant fiscal implication to the State is anticipated.
The bill would amend the Occupations Code and would require the Texas State Board of Pharmacy to adopt rules relating to labeling requirements for drugs dispensed by pharmacists. Based on the information provided by the Texas State Board of Pharmacy, it is assumed that costs associated with implementing the provisions of the bill could be absorbed within existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.